Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Néo-épitopes
Polyarthrite rhumatoïde
Développement clinique
Rectocolite hémorragique
Sjögren
NSCLC
Immunothérapie
Maladies autoimmunes
Biotechnologie
Checkpoint inhibitor
SIRP-alpha
Medical Device
MDSC
Immuno-oncologie
Medical
Date founded
2012
Funding rounds raised
Total raised
$12M
from 3 investors over 3 rounds
O
OSE Immunotherapeutics raised $219K on August 1, 2023
Investors: Gouvernement and Pays de la Loire Europe
O
OSE Immunotherapeutics raised $12M on July 9, 2021
Investors: European Investment Bank